Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diagnostics
Pharma
Roche's rosy pandemic scenario deals a $2B blow to COVID sales
Roche's COVID sales will be $2 billion lighter in 2022, execs said Thursday, but that assumes omicron burns out and immunity is strong.
Tracy Staton
Feb 3, 2022 4:35pm
Horizon partners with MIT for crowdsourced rare disease ideas
Sep 17, 2021 1:28pm
Guardant nabs chief commercial officer from Gilead
Jul 13, 2021 9:05am
Genentech oncology exec moves to Guardant to boost diagnostics
May 24, 2021 9:11am
Roche CEO Schwan rejects U.S.-backed COVID-19 patent waiver
May 13, 2021 12:50pm
AZ new head of diagnostic strategy drives biomarker awareness
Apr 26, 2021 10:34am
